C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
11/2011
11/10/2011	US20110275792 Metal coordinated compositions
11/10/2011	US20110275621 Hiv integrase inhibitors
11/10/2011	US20110275608 Piperidine-containing compounds and use thereof
11/10/2011	DE102010019306A1 Organische Elektrolumineszenzvorrichtungen Organic electroluminescent
11/10/2011	CA2812526A1 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
11/09/2011	EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists
11/09/2011	EP2384756A2 High-purity large-scale preparation of stannsoporfin
11/09/2011	EP2069353B1 Polycyclic agents for the treatment of respiratory syncytial virus infections
11/09/2011	EP2066647B1 Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors
11/09/2011	CN102239172A Hiv整合酶抑制剂 Hiv integrase inhibitors
11/09/2011	CN102234288A Preparation method of zotarolimus
11/09/2011	CN102234287A Nitro imidazole compound, its preparation method and application
11/09/2011	CN102234271A Aryl (alkyl) amino dithio formate compounds, and preparation method and application thereof
11/09/2011	CN101928290B Method for purifying pazufloxacin mesylate
11/08/2011	CA2460572C Dual action antibiotics
11/08/2011	CA2432185C Substituted pyridoindoles as serotonin agonists and antagonists
11/03/2011	WO2011137313A1 Aza-bicyclic amine n-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugs
11/03/2011	WO2011136385A1 Bicyclic compound derivatives and their use as acc inhibitors.
11/03/2011	WO2011134296A1 (6,7-dihydro-2-nitro-5h-imidazol[2,1-b] [1,3]oxazin-6-yl) amide compounds, preparation methods and uses thereof
11/03/2011	US20110269969 Total synthesis of salinosporamide a and analogs thereof
11/03/2011	US20110269787 Azabicyclic Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
11/03/2011	US20110269753 Heterocyclic compounds as phosphodiesterase inhibitors
11/03/2011	US20110269751 Heterocyclic nitrogenous or oxygenous compounds with insecticidal activity formed from dialdehydes and their preparation and uses thereof
11/03/2011	US20110269744 Benzazepine Compound
11/02/2011	EP2383271A1 Aminoquinolones as GSK-3 Inhibitors
11/02/2011	EP2382210A2 Pyrimidinediamine kinase inhibitors
11/02/2011	EP2381775A1 Small molecule inhibitors of necroptosis
11/02/2011	EP2245014B1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
11/02/2011	EP2203458B1 Cyanoaminoquinolones as gsk-3 inhibitors
11/01/2011	US8048890 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents
11/01/2011	US8048879 Substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridine compounds and use thereof for producing medicaments
11/01/2011	US8048878 Two cyclic cinnamide compound
11/01/2011	US8048536 Single-layer organic EL device
11/01/2011	CA2649521C Novel piperazine compound, and use thereof as hcv polymerase inhibitor
11/01/2011	CA2641473C Condensed imidazole derivatives as aldosterone synthase inhibitors
11/01/2011	CA2535749C Ppar activating compound and pharmaceutical composition containing same
11/01/2011	CA2490254C Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
10/2011
10/27/2011	WO2011133182A1 Modulators of 5-ht receptors and methods of use thereof
10/27/2011	WO2011132712A1 Novel hydroxamic acid derivative
10/27/2011	WO2011131135A1 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof
10/27/2011	US20110264026 Azo Derivatives and Uses Thereof in Phototherapy
10/27/2011	US20110263855 Processes and intermediates for carbamoylpyridone hiv integrase inhibitors
10/27/2011	US20110263845 Method for manufacturing heterocycle substituted pyridine derivatives
10/27/2011	US20110263616 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene maleate salt
10/27/2011	US20110263605 Azabicyclo[2.2.1]Heptane Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
10/27/2011	US20110263570 Pyrimidine derivatives as gpcr modulators for use in the treatment of obesity and diabetes
10/27/2011	US20110263567 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
10/27/2011	US20110263562 Bicyclic compound
10/27/2011	US20110263534 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
10/27/2011	US20110263529 Gamma secretase modulators
10/27/2011	CA2797019A1 Modulators of 5-ht receptors and methods of use thereof
10/26/2011	EP2380883A1 Cyclic carbodiimide compounds
10/26/2011	EP2380006A1 A method for determination of sirolimus stability and process for preparing its stable form
10/26/2011	EP2379566A2 Gamma secretase modulators
10/26/2011	EP2379564A1 Bicyclic heterocyclic derivatives and methods of use thereof
10/26/2011	EP2379563A1 Gamma secretase modulators
10/26/2011	EP2379559A2 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
10/26/2011	EP2379530A1 Pyrimidine indole derivatives for treating cancer
10/26/2011	EP2379529A1 Novel compounds
10/26/2011	EP1917269B1 Inhibitors of serine proteases
10/26/2011	EP1425010B1 Substituted indoles and their use as integrin antagonists
10/26/2011	CN102227436A Macrocyclic compounds as hepatitis c virus inhibitors
10/26/2011	CN102227435A Hepatitis c virus inhibitors
10/25/2011	US8044089 3-3-di-substituted-oxindoles as inhibitors of translation initiation
10/25/2011	US8044041 Phthalazine derivatives as inhibitors of protein kinase
10/25/2011	CA2537840C Method for the manufacture of thip
10/25/2011	CA2531454C Use of rapamycin and rapamycin derivatives for the treatment of bone loss
10/20/2011	WO2011130390A1 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
10/20/2011	WO2011129095A1 Pyridone derivative having integrase inhibitory activity
10/20/2011	WO2011128421A1 Tricyclic pyridyl-vinyl pyrroles as par1 inhibitors
10/20/2011	WO2011128279A1 Arylethynyl derivatives
10/20/2011	WO2011128017A1 Bridged triarylamines and -phosphines as materials for electronic devices
10/20/2011	WO2011101304A3 Piperidine derivatives
10/20/2011	WO2011092293A3 Cyclohexyl amide derivatives as crf receptor antagonists
10/20/2011	US20110257168 Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands
10/20/2011	US20110257156 Gamma secretase modulators
10/20/2011	US20110257137 Heterocyclic inhibitors of histamine receptors for the treatment of disease
10/20/2011	CA2792278A1 2,4-pyrimidinediamine compounds and prodrugs thereof and their uses
10/20/2011	CA2786216A1 Arylethynyl derivatives
10/19/2011	EP2377845A1 Heterocyclic nitrogenous or oxygenous compounds with insecticidal activity formed from dialdehydes and their preparation and uses thereof
10/19/2011	EP2377539A1 Quinazoline analogs as receptor tyrosine kinase inhibitors
10/19/2011	EP2376501A1 SPIRO AZEPANE-OXAZOLIDINONES AS Kv1.3 POTASSIUM CHANNEL BLOCKERS
10/19/2011	EP2376500A1 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene maleate salt
10/19/2011	EP2376499A1 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt
10/19/2011	EP2376495A2 Compositions of protein receptor tyrosine kinase inhibitors
10/19/2011	EP2376490A1 Imidazopyridine compounds
10/19/2011	EP2376080A1 Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates
10/19/2011	EP1910379B1 Caspase inhibitor prodrugs
10/19/2011	EP1648870B1 Sulfonic acid derivatives of polycyclic dyes used for analytical applications
10/19/2011	CN102224242A Novel gene cluster
10/19/2011	CN102224159A Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases
10/18/2011	US8039467 Compounds for the treatment of inflammatory disorders
10/18/2011	US8039466 5-hydroxymethyl-oxazolidin-2-one antibacterials
10/18/2011	CA2494557C Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
10/18/2011	CA2398018C Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/13/2011	WO2011124539A1 Bicyclic pyrimidinyl pyrazoles
10/13/2011	US20110251384 Cyclic carbodiimide compounds
10/13/2011	US20110251379 Compounds useful for treating neurodegenerative disorders
10/13/2011	US20110251231 Modified release compositions comprising tacrolimus
10/13/2011	US20110251215 Macrocyclic compounds and their use as kinase inhibitors

1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 220